These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8179062)

  • 1. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses.
    Newman MA; Valanis BG; Schoeny RS; Hee SQ
    Am J Public Health; 1994 May; 84(5):852-5. PubMed ID: 8179062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine.
    Newman MA; Hee SQ; Schoeny R; Lowry L
    Cancer Res; 1990 Jun; 50(11):3351-66. PubMed ID: 2334930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.
    Rekhadevi PV; Sailaja N; Chandrasekhar M; Mahboob M; Rahman MF; Grover P
    Mutagenesis; 2007 Nov; 22(6):395-401. PubMed ID: 17855733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.
    Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J
    Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests.
    Labuhn K; Valanis B; Schoeny R; Loveday K; Vollmer WM
    Cancer Nurs; 1998 Apr; 21(2):79-89. PubMed ID: 9556934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occupational exposure to antineoplastic drugs in a hospital setting: biological and environmental monitoring].
    Barbieri A; Nucci MC; Sabatini L; Risi A; Bolognesi C; Colacci A; Violante FS
    Epidemiol Prev; 2005; 29(5-6 Suppl):87-90. PubMed ID: 16646269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary D-glucaric acid, a marker substance for microsomal enzyme induction. Methodological aspects, responses to alcohol and findings in workers exposed to toluene.
    Sandstad O; Osnes T; Skar V; Osnes M
    Scand J Clin Lab Invest; 1993 Jul; 53(4):327-33. PubMed ID: 8378735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach.
    Moretti M; Grollino MG; Pavanello S; Bonfiglioli R; Villarini M; Appolloni M; Carrieri M; Sabatini L; Dominici L; Stronati L; Mastrangelo G; Barbieri A; Fatigoni C; Bartolucci GB; Ceretti E; Mussi F; Monarca S
    Int Arch Occup Environ Health; 2015 Aug; 88(6):683-95. PubMed ID: 25362515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of occupational exposure to cytostatic anticancer agents.
    Sorsa M; Anderson D
    Mutat Res; 1996 Aug; 355(1-2):253-61. PubMed ID: 8781586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomonitoring of nurses occupationally exposed to antineoplastic drugs: the IMEPA Project].
    Bolognesi C; Nucci MC; Colacci AM; Grilli S; Ippoliti F; Mucci N; Romano Spica V; Barbieri A; Canitano N; Chiozzotto D; Di Renzo L; Giordano E; Horn W; Roggieri P; Risi A; Silingardi P; Vaccari M; Violante FS
    Epidemiol Prev; 2005; 29(5-6 Suppl):91-5. PubMed ID: 16646270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring occupational exposure to cancer chemotherapy drugs.
    Baker ES; Connor TH
    Am J Health Syst Pharm; 1996 Nov; 53(22):2713-23. PubMed ID: 8931813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposure to cyclophosphamide in nurses at a single center.
    Ramphal R; Bains T; Vaillancourt R; Osmond MH; Barrowman N
    J Occup Environ Med; 2014 Mar; 56(3):304-12. PubMed ID: 24481248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure to cytotoxic drugs in two UK oncology wards.
    Ziegler E; Mason HJ; Baxter PJ
    Occup Environ Med; 2002 Sep; 59(9):608-12. PubMed ID: 12205233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of urinary d-glucaric acid assay and its application].
    Hasegawa K; Shimidzu K; Morimoto S; Hachino Y; Hasegawa K; Shono Y; Horiuchi T; Tabuse K; Masui Y; Yamaguchi T; Fujita Y
    Yakugaku Zasshi; 2008 Jan; 128(1):135-40. PubMed ID: 18176065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan.
    Yoshida J; Koda S; Nishida S; Yoshida T; Miyajima K; Kumagai S
    J Oncol Pharm Pract; 2011 Mar; 17(1):29-38. PubMed ID: 20699333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal biomonitoring of nurses handling antineoplastic drugs.
    Mader RM; Kokalj A; Kratochvil E; Pilger A; Rüdiger HW
    J Clin Nurs; 2009 Jan; 18(2):263-9. PubMed ID: 18624785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occupational exposure to genotoxic agents with a urinary mutagen assay.
    Kriebel D; Commoner B; Bollinger D; Bronsdon A; Gold J; Henry J
    Mutat Res; 1983 Mar; 108(1-3):67-79. PubMed ID: 6835232
    [No Abstract]   [Full Text] [Related]  

  • 19. Exposure to toluene increases the urinary excretion of D-glucaric acid.
    Moretto A; Lotti M
    Br J Ind Med; 1990 Jan; 47(1):58-61. PubMed ID: 2310708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handling anticancer drugs: from hazard identification to risk management?
    Sorsa M; Hämeilä M; Järviluoma E
    Ann N Y Acad Sci; 2006 Sep; 1076():628-34. PubMed ID: 17119240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.